$HSIC

HENRY SCHEIN INC

3
1
0

No SEC Form 4 filings for $HSIC in the last 30 days.

Med

Henry Schein AGM Marks Bergman Exit, Lowery Era and Governance Shift

Henry Schein (HSIC) held its virtual 31st annual meeting, with Chairman Stanley Bergman presiding, and stockholders voting on director elections, executive pay (non-binding), auditor ratification, and a governance proposal. Bergman said he will step down and become chairman emeritus; Fred Lowery became CEO on March 2, 2026. Ten directors were elected to 2027 terms; BDO USA was ratified. A preliminary vote approved a proposal to move from supermajority to majority voting.

Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board, Succeeding Stan Bergman After 44 Years

Henry Schein, Inc. has announced the election of William K. “Dan” Daniel as the new Independent Chairman of the Board, effective May 21, 2026. This appointment follows the retirement of long-serving Chairman Stanley M. Bergman, who has been named Chairman Emeritus after 44 years with the company. The transition occurs as Henry Schein continues to implement its strategy to become a leading integrated solutions platform in healthcare, with Daniel bringing extensive executive experience from Danaher Corporation to his new role.

Henry Schein appoints William Daniel as independent chairman

Henry Schein, Inc. has announced the election of William K. Daniel as its Independent Chairman of the Board, effective May 21, 2026. Daniel succeeds Stanley M. Bergman, who retired after 44 years and was named Chairman Emeritus. Daniel joined the board in May 2025 and previously served as Executive Vice President at Danaher Corporation, overseeing its dental portfolio.

News on $HSIC

HSIC news & sentiment — HENRY SCHEIN INC | alphai